Renmark Virtual Non-Deal Roadshow: TSX - HLS

Financial Advisors, Investment Advisors, Analysts, and Institutional Portfolio Managers are cordially invited to attend a presentation for: Corporate Presentation In Toronto
Mar, 19, 2021 - 11:00 AM EDT
- , Toronto, Ontario

HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), Montreal (Dorval, Quebec) and Philadelphia (Rosemont, Pennsylvania).  We source our products from the drug’s originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada’s regulations.